Acute myocardial infarction
Acute myocardial infarction (AMI) refers to acute necrosis of part of the myocardium due to persistent and severe myocardial ischemia. Clinically, it is often manifested as chest pain, acute circulatory dysfunction, and a series of characteristic electrocardiogram changes reflecting myocardial damage, ischemia, and necrosis. Clinical manifestations often include persistent severe pain behind the sternum, acute circulatory dysfunction, arrhythmia, heart failure, fever, elevated white blood cell count and serum myocardial injury marker enzymes, and progressive electrocardiogram changes of acute myocardial damage and necrosis. According to the scope of infarction, myocardial infarction can be divided into two categories: transmural myocardial infarction and subendocardial myocardial infarction. According to the development process of the lesion, myocardial infarction can be divided into acute myocardial infarction and old myocardial infarction.
Related Drugs
Metoprolol Tartrate Injection
Indication: Supraventricular tachyarrhythmias. Prevention and treatment of myocardial ischemia, suspected or confirmed acute myocardial infarction with tachyarrhythmias and chest pain.
Manufacturer:
Zhuhai Rundu Pharmaceutical Co., Ltd.
glycerin
Indication: 1. Treat and prevent angina pectoris. 2. Used for acute myocardial infarction. Early application (first 24 hours) can reduce mortality and complications of anterior wall infarction, and has a beneficial effect on the dilation of the long and short diameters of the left ventricle and thinning of the ventricular wall. 3. Used for congestive heart failure. 4. Can also be used to treat hypertension.
Manufacturer:
Nanchang Baiyun Pharmaceutical Co., Ltd.
Metoprolol Tartrate for Injection
Indication: Supraventricular tachyarrhythmias. Prevention and treatment of myocardial ischemia, suspected or confirmed acute myocardial infarction with tachyarrhythmias and chest pain.
Manufacturer:
Hainan Tongyong Kangli Pharmaceutical Co., Ltd.
Metoprolol Tartrate for Injection
Indication: Supraventricular tachyarrhythmias. Prevention and treatment of myocardial ischemia, suspected or confirmed acute myocardial infarction with tachyarrhythmias and chest pain.
Ramipril Tablets
Indication: Essential hypertension; mild to moderate heart failure (NYHA II and III) occurring 2-9 days after acute myocardial infarction.
Ramipril Tablets
Indication: Essential hypertension; congestive heart failure; mild to moderate heart failure after acute myocardial infarction (2 to 9 days).
Manufacturer:
Kun Shan Rotam Reddy Pharmaceutical Co., Ltd.
Ramipril Tablets
Indication: Essential hypertension; congestive heart failure; mild to moderate heart failure after acute myocardial infarction (2 to 9 days).
Manufacturer:
Kun Shan Rotam Reddy Pharmaceutical Co., Ltd.
Ramipril Tablets
Indication: Hypertension. Congestive heart failure. Symptoms of congestive heart failure that occur within the first few days after an acute myocardial infarction.
Ramipril Tablets
Indication: Hypertension. Congestive heart failure. Symptoms of congestive heart failure that occur within the first few days after an acute myocardial infarction.
Lidocaine Hydrochloride Injection (Solvent)
Indication: This product is a local anesthetic and antiarrhythmic drug. It is mainly used for infiltration anesthesia, epidural anesthesia, surface anesthesia (including mucosal anesthesia during thoracoscopy or abdominal surgery) and nerve conduction block. This product can also be used for ventricular premature beats and ventricular tachycardia after acute myocardial infarction, and can also be used for ventricular arrhythmias caused by digitalis poisoning, cardiac surgery and cardiac catheterization. This product is usually ineffective for supraventricular arrhythmias.
Manufacturer:
Yusongyuan Pharmaceutical Co., Ltd.